Location History:
- Goettingen, DE (2022)
- Göttingen, DE (2022)
Company Filing History:
2 out of 5,448 
2 out of 6 
1 out of 1 Years Active: 2022-2025
Title: Innovations by Elisabeth Zeisberg
Introduction
Elisabeth Zeisberg is a prominent inventor based in Goettingen, Germany. She has made significant contributions to the field of medical research, particularly in the prevention and treatment of chronic organ injuries. With a total of 3 patents to her name, her work is paving the way for novel therapeutic approaches.
Latest Patents
One of her latest patents focuses on the prevention or treatment of chronic organ injury. This patent discloses innovative agents aimed at increasing homodimer-formation of ARNT in organs, which can help prevent or delay the progression of chronic injuries and fibrosis. Another notable patent involves a method for re-expressing hypermethylated genes, such as RASAL1, LRFN2, and KLOTHO, which are crucial in treating fibrosis and other disorders. This method utilizes an inactivated CRISPR-based system and a DNA dioxygenase to guide the constructs for demethylation, allowing for the re-expression of these important genes.
Career Highlights
Elisabeth has worked with esteemed institutions, including the University of Texas System and Georg-August-University Göttingen. Her research has significantly impacted the understanding and treatment of chronic organ injuries and related conditions.
Collaborations
Throughout her career, Elisabeth has collaborated with notable colleagues, including Michael Zeisberg and Gerhard Anton Mueller. These partnerships have enhanced her research and contributed to her innovative work in the field.
Conclusion
Elisabeth Zeisberg's contributions to medical research through her patents and collaborations highlight her role as a leading inventor in the field. Her innovative approaches to treating chronic organ injuries and related conditions are paving the way for future advancements in healthcare.